Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Landow

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Clinical Neuropharmacology|August 1, 1989
Continuous oral administration of L-dihydroxyphenylalanine (L-DOPA) solution to patients with advanced Parkinson's diseaseJ P Bennett, M Turk, E Landow
Birth Defects Original Article Series|January 1, 1975
Craniodiaphyseal dysplasiaI Kaitila, R E Stewart, E Landow, et al.
Neurology|September 1, 1994
The effect of deprenyl and tocopherol on cognitive performance in early untreated Parkinson's disease. Parkinson Study GroupK Kieburtz, M McDermott, P Como, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Clinical Neuropharmacology|August 1, 1989
Continuous oral administration of L-dihydroxyphenylalanine (L-DOPA) solution to patients with advanced Parkinson's diseaseJ P Bennett, M Turk, E Landow
Birth Defects Original Article Series|January 1, 1975
Craniodiaphyseal dysplasiaI Kaitila, R E Stewart, E Landow, et al.
Neurology|September 1, 1994
The effect of deprenyl and tocopherol on cognitive performance in early untreated Parkinson's disease. Parkinson Study GroupK Kieburtz, M McDermott, P Como, et al.
Pageof 1